Genomics Institute of the Novartis Research Foundation
Triazolopyridine compounds and uses thereof
A compound of Formula (IA), or a pharmaceutically acceptable salt thereof, is provided that has been shown to be useful for treating a PRC2-mediated disease or disorder: wherein A, R6, R7 and R8 are as defined herein. 
Novartis AG
C A
C07D A61P
inventional inventional
Kehao Hailong Ho Man Qiong Xingnian Long Zhengtian Man Wei Ying Martin Yuan Ling Yongfeng Xiang-Ju Justin Ji Yue
Zhao Zhang Chan Zhang Fu Wang Yu Zhang Qi Huang Sendzik Mi Li Sun Gu Zhang